Codex 10 Envelopes 5 MLD 250mg,Codex 10 Buste 5 MLD 250mg,ZAMBON ITALIA SRL

“ACTIVE INGREDIENTS: Saccharomyces boulard 5 billion live microbes (as 250 mg lyophilized powder).
Excipients: Lactose monohydrate, fructose, anhydrous colloidal silicon dioxide, all fruit flavor.
INDICATIONS: Prevention and treatment of intestinal dismicrobismo induced by antibiotics and sulfonamides and disvitaminosi from them. Therapy of acute diarrhea of various etiologies. Prevention and treatment of traveler’s diarrhea. Therapy for irritable bowel syndrome with alvo has been changed. Therapy of candidiasis in the gastrointestinal tract.
CONTRAINDICATIONS/EFF.SECONDARY: Hypersensitivity to the active substance or to any of the excipients. Patients with a central venous catheter. Allergy to yeast.
DOSAGE: Adults: 1-2 sachets 2 times a day. Children from 0 to 3 years: 1 sachet 2 times a day. Children from 3 to 12 years: 1 sachet 3 times a day no. Unless otherwise prescribed by a doctor. It is recommended that administration be done at regular intervals, if possible on an empty stomach or at least 15 minutes before meals. During therapy with antibiotics, the drug is rarely administered at the same time. For infants or children, it is recommended to pour the contents of the sachet into bottles or liquids with sugar.
WARNINGS: Do not mix with liquids that are too hot or alcohol solution. Given the nature of the fungal Saccharomyces boulard, no topical or systemic antifungal therapy should be given during treatment. Treatment of diarrhea there is no replacement for reidratazio when necessary.
INTERACTIONS: Given the fungal nature of Saccharomyces boulard, do not use topically or systemically during antifungal therapy.
SIDE EFFECTS: After introduction to the Code, rare cases of flatulence, and rare cases of allergic reactions in the form of facial swelling (angioedema) and/or itching, itchy blisters (urticaria) and rash l ocalizzati or systemic were reported. In addition, rare cases of anaphylactic reaction or shock have been reported. Report any negative reaction to the hospital through the national reporting system.
PREGNANCY AND BREAST-FEEDING: Reliable data on teratogenic factors cited in animals are not available. Clinically, no cases of painful formations or embryotoxic effects have been reported. However, since the data obtained from the observation of pregnant women exposed to drugs is insufficient, you cannot exclude any risk. Although Saccharomyces boulard has not been absorbed, its administration during pregnancy and breastfeeding should only be carried out in cases of real need under the direct supervision of a physician who will assess the risk/benefit ratio.”